WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study

Autor: Embaby, Alaa, Kutzera, Joachim, Geenen, Jill J., Pluim, Dick, Hofland, Ingrid, Sanders, Joyce, Lopez-Yurda, Marta, Beijnen, Jos H., Huitema, Alwin D.R., Witteveen, Petronella O., Steeghs, Neeltje, van Haaften, Gijs, van Vugt, Marcel A.T.M., de Ridder, Jeroen, Opdam, Frans L.
Zdroj: In Gynecologic Oncology July 2023 174:239-246
Databáze: ScienceDirect
Externí odkaz: